These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37273900)

  • 1. A novel dual-plasmid platform provides scalable transfection yielding improved productivity and packaging across multiple AAV serotypes and genomes.
    van Lieshout LP; Rubin M; Costa-Grant K; Ota S; Golebiowski D; Panico T; Wiberg E; Szymczak K; Gilmore R; Stanvick M; Burnham B; Gagnon J; Iwuchukwu I; Yang G; Ghazi I; Meola A; Dickerson R; Thiers T; Mustich L; Hayes A; Rivas I; Lotterhand J; Avila N; McGivney J; Yin J; Kelly T
    Mol Ther Methods Clin Dev; 2023 Jun; 29():426-436. PubMed ID: 37273900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus.
    Tang Q; Keeler AM; Zhang S; Su Q; Lyu Z; Cheng Y; Gao G; Flotte TR
    Biores Open Access; 2020; 9(1):219-228. PubMed ID: 33117614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes.
    Nass SA; Mattingly MA; Woodcock DA; Burnham BL; Ardinger JA; Osmond SE; Frederick AM; Scaria A; Cheng SH; O'Riordan CR
    Mol Ther Methods Clin Dev; 2018 Jun; 9():33-46. PubMed ID: 29349097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel tools for production and purification of recombinant adenoassociated virus vectors.
    Grimm D; Kern A; Rittner K; Kleinschmidt JA
    Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
    Grieger JC; Soltys SM; Samulski RJ
    Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational plasmid design and bioprocess optimization to enhance recombinant adeno-associated virus (AAV) productivity in mammalian cells.
    Emmerling VV; Pegel A; Milian EG; Venereo-Sanchez A; Kunz M; Wegele J; Kamen AA; Kochanek S; Hoerer M
    Biotechnol J; 2016 Feb; 11(2):290-7. PubMed ID: 26284700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.
    Wang XS; Ponnazhagan S; Srivastava A
    J Virol; 1996 Mar; 70(3):1668-77. PubMed ID: 8627687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.
    Grimm D; Kay MA; Kleinschmidt JA
    Mol Ther; 2003 Jun; 7(6):839-50. PubMed ID: 12788658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery.
    Chahal PS; Schulze E; Tran R; Montes J; Kamen AA
    J Virol Methods; 2014 Feb; 196():163-73. PubMed ID: 24239634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic model for production of recombinant adeno-associated virus via triple transfection of HEK293 cells.
    Nguyen TNT; Sha S; Hong MS; Maloney AJ; Barone PW; Neufeld C; Wolfrum J; Springs SL; Sinskey AJ; Braatz RD
    Mol Ther Methods Clin Dev; 2021 Jun; 21():642-655. PubMed ID: 34095346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Only a small fraction of cells produce assembled capsids during transfection-based manufacturing of adeno-associated virus vectors.
    Dash S; Sharon DM; Mullick A; Kamen AA
    Biotechnol Bioeng; 2022 Jun; 119(6):1685-1690. PubMed ID: 35182435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OneBac 2.0: Sf9 Cell Lines for Production of AAV1, AAV2, and AAV8 Vectors with Minimal Encapsidation of Foreign DNA.
    Mietzsch M; Hering H; Hammer EM; Agbandje-McKenna M; Zolotukhin S; Heilbronn R
    Hum Gene Ther Methods; 2017 Feb; 28(1):15-22. PubMed ID: 28125901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of genome size on AAV vector packaging.
    Wu Z; Yang H; Colosi P
    Mol Ther; 2010 Jan; 18(1):80-6. PubMed ID: 19904234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the design space of AAV transient-transfection in suspension cell lines.
    Meade O; Clark J; McCutchen M; Kerwin J
    Methods Enzymol; 2021; 660():341-360. PubMed ID: 34742397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of adeno-associated viral vector serotype 6 by triple transfection of suspension HEK293 cells at higher cell densities.
    Moço PD; Xu X; Silva CAT; Kamen AA
    Biotechnol J; 2023 Sep; 18(9):e2300051. PubMed ID: 37337925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A self-complementary AAV proviral plasmid that reduces cross-packaging and ITR promoter activity in AAV vector preparations.
    Taylor NK; Guggenbiller MJ; Mistry PP; King OD; Harper SQ
    Mol Ther Methods Clin Dev; 2024 Sep; 32(3):101295. PubMed ID: 39139628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic production of nanogels as alternative triple transfection reagents for the manufacture of adeno-associated virus vectors.
    Whiteley Z; Massaro G; Gkogkos G; Gavriilidis A; Waddington SN; Rahim AA; Craig DQM
    Nanoscale; 2023 Mar; 15(12):5865-5876. PubMed ID: 36866741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale.
    Lock M; Alvira M; Vandenberghe LH; Samanta A; Toelen J; Debyser Z; Wilson JM
    Hum Gene Ther; 2010 Oct; 21(10):1259-71. PubMed ID: 20497038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.